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The familial tendency of diabetes has been recognized for centuries. The genetic studies of Pincus
and White (1933) , Steinberg and
Wilder (1952), Post (1962), and
others seem to indicate that diabetes is transmitted as a simple
autosomal recessive trait. If this is
so, it is obvious that the tendency
to diabetes must be established at
the moment of conception. What
does this tendency to diabetes consist of, and what determines when
the disease we have called "diabetes" will appear? What is the
status of the predisposed individual
prior to the onset of overt diabetes?
It has long been known that
large babies are often born to
mothers later destined to become
diabetic. This and the observation
that transient diabetes during pregnancy or other stress is often the
forerunner of later overt diabetes
led Jackson (1960), Conn and
Fajans (1961), and others to regard this period before the development of obvious diabetes as an important one, a period of active
dynamic changes which culminate
in the appearance of clinical diabetes. Jackson, and Conn and Fajans have called this period "prediabetes. " Others prefer the term,
"diabetes premellitus."
We might define diabetes as a
genetically determined metabolic
disease, the predisposition to which
is established at conception. It may
ultimately progress to the stage of
clinical diabetes with insulin insufficiency and the accompanying
manifestations of hyperglycemia,
glycosuria, and abnormal metabolism of protein and fat.
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ST AGES OF DIABETES

The life history of a diabetic patient may be regarded as consisting
of three stages: (I) prediabetes,
(II) asymptomatic or chemical diabetes, and (III) overt or symptomatic diabetes. Asymptomatic or
chemical diabetes is sometimes
further divided into diabetes present only with stress, and diabetes
present without stress (Table 1).
In general, the di abetic patient
appears to progress through one
stage to the next, although in some
patients, stage II is either very brief
or unrecognized, and many diabetics may remain asymptomatic
and never reach stage III. Diabetes
appearing early in life is more
likely to be severe, and diabetes developing late in life generally is
mild and often asymptomatic. Some
factors that can alter the natural
course of diabetes are illustrated in
Figures 1 and 2.
VASCULAR DISEASE AND
BIOCHEMICAL CHANGES IN
PREDIABETIC STATE

It would appear that the key to
better understanding of the pathophysiology of diabetes might be
found in the events occurring in the
prediabetic period. The first problem lies in knowing how to recognize the prediabetic patient, since,
by definition, all tests of carbohydrate metabolism are normal in this
state. Camerini-Diivalos ( 1965a and
b), Rees and their colleagues (1964)
.have attacked the problem by studying a group of children who were
either the identical twins of diabetic patients or the children of two

diabetic parents. Such children
should all be genetically prediabetic, although all need not develop
diabetes. These authors have marshalled impressive evidence both of
beginning vascular disease of the
diabetic type, and of certain biochemical abnormalities preceding
the development of chemically detectable diabetes.
Vascular abnormalities found in
prediabetes include: (a) abnormal
finger pulse waves (CameriniDiivalos, 1965a), (b) venular dilatation in the bulbar conjunctiva
with increased venule : arteriole diameter ratio (Camerini-Diivalos et
al., 1964), (c) thickened basement
membrane of capillaries on gingival
biopsy (Camerini-Diivalos, 1965b),
(d) on ear lobe biopsy (CameriniDiivalos et al., 1964), and (e) in
the glomerular capillaries on renal
biopsy ( Camerini-Diivalos, 1965a).
In addition it seems likely that
some fetal abnormalities in babies
of prediabetic mothers may result
from vascular disturbances in the
placenta.
Chemical changes reported in
prediabetes include the following :
(a) Although the glucose tolerance
test of the prediabetic is within normal limits, the mean blood sugar of
all prediabetics is significantly
higher than that of non-prediabetic
controls at 1, 1 V2, 2 and 3 hours
after glucose. (b) In prediabetics
the fasting serum free fatty acids
are increased, and their fall after
glucose is delayed. ( c) Serum sialic
acid is increased in prediabetes.
( d)
Serum insulin-like-activity
(ILA) is increased fasting and after
glucose (Camerini-Diivalos, 1965a).
( e) Synalbumin insulin antagonist
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of Vallance-Owen is increased
(Vallance-Owen and Ashton, 1963).
(f) "Bound" insulin of Antoniades
is increased (Camerini-Davalos,
1965a). (g) Prediabetics show an
increased rise in blood growth hormone three hours after glucose, following the initial supression of
growth hormone levels by the glucose (Unger, 1965).
Many of these biochemical
changes are slight and many need
confirmation. The significance of
increases in ILA or in "bound" insulin is in dispute. Nevertheless it
does appear that there are biochemical abnormalities during prediabetes. Among these observations
the most significant would seem to
be the finding of increased amounts
of insulin in the blood, even by immunoassay when measured 1 hour
after glucose, not only in prediabetics, but early in the course of
juvenile diabetes, and in most
maturity-onset diabetics. The finding of a high insulin level at a time
when blood sugar is high challenges
our earlier concept of diabetes as a
manifestation of simple insulin insufficiency. There must be a reason
for the apparent ineffectiveness of
insulin. This question is at the heart
of much of the investigation in diabetes today. Some of the possible
causes for insulin ineffectiveness
that have been proposed are listed
in Table 2.

THE PRIMARY METABOLIC
DEFECT IN DIABETES

Whatever mechanism is ultimately found to be responsible for
insulin antagonism, current thinking strongly favors the concept that
the primary event in diabetes is not
pancreatic failure, but extrapancreatic antagonism to insulin or inactivation of insulin of some sort. As
available active insulin diminishes,
some form of feedback mechanism,
possibly a transitory rise in blood
glucose, causes the pancreas to release more insulin until a new
equilibrium is reached. During the
stage of prediabetes, this compensa-

TABLE 1
Stages in Life History of a Diabetic

I. Prediabetes

II. Asymptomatic or
Chemical Diabetes

From conception to first evidence of
impaired insulin reserve. No demonstrabl e abnormality in carbohydrate
metabolism.

(a) With stress only:
Blood sugar (BS) elevated only with
stress, such as i.nfection or pregnancy.
Glucose tolerance test (GTT) normal.
Cortisone GTT abnormal.
(b) Present without stress:
Postprandial BS elevated. Fasting
BS normal or slightly elevated. Little
or no g lycosuria. GTT abnormal.

Ill. Symptomatic or
Overt Diabetes

Persistent hyperglycemia and glycosuria.
Po lyuria, thirst, etc. G TT not necessary.

tory process is able to maintain
normal or nearly normal carbohydrate metabolism. If the antagonism
to insulin continues, the pancreas
may be driven to the point of failure. Such islet cell failure may be
first manifest by inability to release
insulin promptly in response to a
rise in blood glucose. The process
may be at first reversible to some
extent, but later becomes irreversible with more or less complete failure of insulin secretion. This seems
to be the case with many juvenile
diabetics where early remission occurs after institution of treatment,
only to be followed in a few months
by total and permanent pancreatic
failure. In the maturity-onset diabetic, the antagonism to insulin is
less severe; pancreatic failure develops only late in life and seldom
becomes complete. In many such
patients the use of sulfonylurea
drugs improves the release of insulin by the ft-cells to a degree adequate to maintain carbohydrate
homeostasis.

VASCULAR COMPLICATIONS
OF DIABETES

The vascular disease of diabetes
is chiefly a microangiopathy, i.e., a
degenerative change in capillaries,
venules, and arterioles throughout
the body that eventually produces
such pathologic lesions as retinopathy, glomerulosclerosis, and possibly neuropathy. These complications were formerly thought to
result from years of deranged metabolism. The discovery of incipient
microangiopathy in various sites in
prediabetes and in the early stages
of chemical diabetes casts doubt on
the view that these changes result
solely from the metabolic abnormality produced by insulin deficiency and supports the view that
the metabolic disturbance and the
vascular disease may be independent facets of the fundamental
genetic disease. On the other hand,
there is a sizeable body of clinical
opinion that the progression of vascular disease is more severe in
3

NATURAL HISTORY OF DIABETES

OVERT OR
SYMPTOMATIC
DIABETES

CHEMICAL OR
ASYMPTOMATIC
DIABETES

PREDIABETES

10

20

30

40

50

60

70

80

AGE

Fig. 1-The course of diabetes with age is indicated as a line sloping upward as
the disease becomes more severe. Prediabetes is indicated as a clear zone, and
diabetes is indicated by stippling, which is heavier toward the top as the disease
becomes more severe. The juvenile diabetic progresses rapidly through prediabetes and asymptomatic diabetes to the abrupt onset of overt diabetes, usually
severe and with obvious symptoms. The maturity-onset diabetic follows a line
with a smaller slope and reaches the stage of chemical diabetes in middle life.
Other predisposed individuals may never develop diabetes at all. Along this
course or life-curve, events producing stress such as pregnancy or infection can
make diabetes worse and can bring out chemical or even symptomatic diabetes
in a prediabetic individual. When stress is removed, diabetes may return to its
previous undetectable state, or at least to a subclinical or asymptomatic state.

those patients with the greatest
metabolic abnormality, although
Knowles ( 1964), reviewing all the
literature, did not believe the question could be answered on the present evidence. The appearance of
retinitis and glomerulosclerosis in
patients with diabetes resulting from
hemochromatosis (Becker and Miller, 1960) or pancreatitis, and the
observation that similar lesions develop in dogs made diabetic by alloxan or growth hormone (Bloodworth, 1965), bring us back to the
role of insulin deficiency and altered metabolism in the genesis of
the vascular lesion. The fact that
the glucose tolerance tests of prediabetics, while normal, show significantly higher blood sugar levels
after glucose than in non-prediabetics suggests that there may already be some deficiency of effective insulin, which could be a factor
in the appearance of vascular abnormalities at this stage. The final
answers to these questions are unknown. In the meantime, our position should admit the possibility of
both genetic and metabolic factors.
It would seem reasonable to use the
measures of treatment available to
keep the chemistry of the diabetic
as near normal as possible, while
continuing the search for genetic or
other factors that may be involved
in the vascular degenerative process.

OVERT OR
SYMPTOMATIC
DIABETES

CHEMICAL OR
ASYMPTOMATIC
DIABETES

TABLE 2
Possible Causes of Insul in Ineffectiveness

Considered, but ruled out:
I.Abnormal insulin
2 . lncreosed insulin destruction

PRE DIABETES

Currently suggested:
I. Binding or inactivation of insulin:
a. free and bound" (Antoniades,
1964)
b. 11 Typical 11 and 11 atypical 11 (Samoan,
1963)
2. Synalbvmin insul in antagonist
(Vallance-Owen , 1964)
3. FFA inhibition of insulin action
(Randle, 1963)
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Fig. 2-Effect of obesity and weight reduction on the course of diabetes. Obesity
often converts prediabetes or mild asymptomatic diabetes to overt diabetes. With
weight reduction alone, the diabetes may disappear entirely or revert to a mild
asymptomatic state.
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4. Growth hormone
5. Auto-immune process
6. Tissue resistance to insulin
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